Date: 2025/04/02 - 23:00
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/03/30 - 18:32
While CRC is on the rise in people under 50, receiving colonoscopies beginning at age 45 can help decrease your risk. Additionally, making lifestyle changes can also help reduce your risk for CRC.
Date: 2025/03/29 - 10:31
New-onset type 2 diabetes was linked to an increased risk for developing certain cancers typically related to obesity, including colorectal, pancreatic, and liver cancers. This increased risk was greater in men than in women.
Date: 2025/03/28 - 12:00
People with inflammatory bowel disease (IBD) or Parkinson’s disease have depletions in similar types of beneficial bacteria, which could help explain the link between both conditions, a new microbiome study has found.
Date: 2025/03/20 - 23:32
A retrospective study found that cannabis users were six times as likely to have a heart attack compared to non-users, while a large meta-analysis of 12 previous studies showed that cannabis users had a 50% higher risk of a heart attack.
Date: 2025/03/20 - 00:00
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP-1s say they may not be able to afford brand-name versions, which are often not covered by insurance.